Kyverna Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2024 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Kyverna Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2024 to Q3 2024.
  • Kyverna Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 31, 2024 was 43.2M shares.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 43.2M Oct 31, 2024 10-Q 2024-11-13
Q2 2024 43.1M Jul 31, 2024 10-Q 2024-08-12
Q1 2024 43.1M May 10, 2024 10-Q 2024-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.